
ArcaScience
A double AI tool which is able to tap and leverage massive biomedical data, enrich it, and associate it with a simple querying and cutting-edge in-depth targeting and extraction tool.
- dt and ls
- biotechnology
- horizon europe
- core ai
- radar de l'innovation
- ai applications
- tech for business
- eit ecosystem
- observatoire deeptech
- eit health
- biotech, medtech and e-health
- ai drug discovery
- techbio
- digital pharma
- techbio drug discovery
- mentoring and coaching network (eit health)
- mentoring and coaching network 2020 (eit health)
- living labs and test beds (eit health)
- living labs and test beds 2020 (eit health)
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
* | €620k | Seed | |
Total Funding | 000k |
Related Content
ArcaScience, established in 2018, operates an AI-driven platform designed to enhance drug development decisions. The company's primary clients are pharmaceutical companies and contract research organizations (CROs). By leveraging artificial intelligence, the platform analyzes extensive datasets to extract insights that can optimize the entire drug lifecycle.
The core of ArcaScience's offering is its ability to process and interpret complex biological and clinical data, aiming to accelerate the delivery of new treatments to patients. The company has established partnerships with major industry players, including Sanofi, Takeda, and Roche, indicating a focus on collaborative efforts within the pharmaceutical sector.
The business model appears to be centered on providing its AI platform as a service to its partners, helping them to make more informed decisions in their drug development processes. This approach is positioned to reduce the time and cost associated with bringing new therapies to market.
Keywords: AI in drug discovery, pharmaceutical data analysis, clinical trial optimization, drug lifecycle management, CRO services, precision medicine, big data in pharma, therapeutic development, computational biology, healthcare AI